Cardiovascular Imaging Registry of Canada
CIROC
1 other identifier
observational
45,000
1 country
4
Brief Summary
A multi-site, multi-modality prospective observational clinical outcomes study focussed on the development of phenotype-dirven risk prediction modelling in patients with known or suspected cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2014
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 26, 2020
CompletedFirst Posted
Study publicly available on registry
April 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2030
ExpectedMarch 12, 2024
March 1, 2024
11 years
April 26, 2020
March 11, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Major adverse cardiovascular outcomes (MACE)
Composite of all-cause death, heart failure admission, myocardial infarction, heart transplantation or LVAD, Stroke or TIA
2024
Malignant arrhythmic events
Composite of sudden cardiac death or appropriate ICD shock
2024
Heart failure events
Composite of heart failure admission, death or need for transplantation / LVAD
2024
Atrial arrhythmic events
Occurrence of atrial fibrillation / atrial flutter (documented by 12-lead ECG or Holter monitor)
2024
All-cause mortality
Death based on Vital Statistics Alberta and In-hospital coded death
2024
Study Arms (1)
Patients with known or suspected cardiovascular disease
All patients with known or suspected cardiovascular disease are studied with a-priori stratification of specific disease-based cohorts.
Interventions
Eligibility Criteria
All patients referred for hospital based cardiac imaging services are considered eligible and are routinely approached using automated patient engagement tools and consent management services.
You may qualify if:
- All patients referred for hospital-based cardiac imaging services
You may not qualify if:
- Failure or provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- Alberta Health servicescollaborator
Study Sites (4)
Foothills Medical Centre
Calgary, Alberta, T2N2T9, Canada
South Health Campus
Calgary, Alberta, T3M1M4, Canada
Peter Lougheed Hospital
Calgary, Alberta, Canada
Rockyview Hospital
Calgary, Alberta, Canada
Related Publications (1)
Purmah Y, Lei LY, Dykstra S, Mikami Y, Cornhill A, Satriano A, Flewitt J, Rivest S, Sandonato R, Seib M, Lydell CP, Howarth AG, Heydari B, Merchant N, Bristow M, Fine N, Gaztanaga J, White JA. Right Ventricular Ejection Fraction for the Prediction of Major Adverse Cardiovascular and Heart Failure-Related Events: A Cardiac MRI Based Study of 7131 Patients With Known or Suspected Cardiovascular Disease. Circ Cardiovasc Imaging. 2021 Mar;14(3):e011337. doi: 10.1161/CIRCIMAGING.120.011337. Epub 2021 Mar 16.
PMID: 33722059DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
James White
Director of Stephenson Cardiac Imaging Centre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, FRCP(C) Director - Stephenson Cardiac Imaging Centre
Study Record Dates
First Submitted
April 26, 2020
First Posted
April 29, 2020
Study Start
August 1, 2014
Primary Completion
August 1, 2025
Study Completion (Estimated)
August 1, 2030
Last Updated
March 12, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share